Connexins in neurons and glia：targets for intervention in disease and injuryKeith B Moore, John OBrien1013-1017
The treatment of Parkinson’s disease with deep brain stimulation：current issuesAlexia-Sabine Moldovan, Stefan Jun Groiss, Saskia Elben, Martin Südmeyer, Alfons Schnitzler, Lars Wojtecki1018-1022
Glycogen and amyloid-beta：key players in the shift from neuronal hyperactivity to hypoactivity observed in Alzheimer’s disease?Britanny Bass, Sarah Upson, Kamolika Roy, Emily L. Montgomery, Tuula O. Jalonen, Ian V.J.Murray1023-1025
Role of mitochondria in regulating microRNA activity and its relevance to the central nervous systemWang-Xia Wang, JoeE.Springer1026-1028
Dendrimer nanocarriers drug action：perspective for neuronal pharmacologyFelipe Vidal, Leonardo Guzman1029-1031
“To measure is to know”：how advances in image analysis are supporting neural repair strategiesPascal Vallotton, Robert Michail Ivan Kapsa1040-1042
